Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
December 18, 2013 -- The U.S. Food and Drug Administration today approved
Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the
once-daily, long-term maintenance treatment of airflow obstruction in patients
with chronic obstructive pulmonary disease (COPD).